α-Helix-Mimetic Foldamers for Targeting HIV-1 TAR RNA

被引:20
作者
Maity, Debabrata [1 ]
Kumar, Sunil [1 ]
Curreli, Francesca [2 ]
Debnath, Asim K. [2 ]
Hamilton, Andrew D. [1 ]
机构
[1] NYU, Dept Chem, New York, NY 10003 USA
[2] New York Blood Ctr, Lindsey F Kimball Res Inst, New York, NY 10065 USA
关键词
anti-HIV; foldamers; oligopyridylamides; peptidomimetics; RNA recognition; HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE; NONCODING RNAS; BINDING MODE; PROTEIN; RECOGNITION; PEPTIDE; DESIGN; REGION; BULGE;
D O I
10.1002/chem.201900139
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
An oligopyridylamide-based foldamer approach has been employed to target HIV TAR RNA-TAT assembly as a model system to study RNA-protein interactions. The oligopyridylamide scaffold adopts a constrained conformation which presents surface functionalities at distinct spatial locations and mimic the chemical features of the secondary structure of proteins. We have designed a library of oligopyridylamides containing diverse surface functionalities which mimic the side chain residues of the TAT protein domain. The interaction of TAR RNA and TAT plays a pivotal role in facilitating HIV replication. The library was screened using various fluorescent based assays to identify antagonists of the TAR RNA-TAT complex. A tricationic oligopyridylamide ADH-19, possessed the highest affinity towards TAR and efficiently inhibited the TAR RNA-TAT interaction with apparent K-d of 4.1 +/- 1.0 mu m. Spectroscopic studies demonstrated that ADH-19 interacts with the bulge and the lower bulge regions of TAR RNA, the domains important for TAT interaction. ADH-19 demonstrated appreciable in vivo efficacy (IC50=25 +/- 1 mu m) by rescuing TZM-bl cells infected with the pseudovirus HIV-1HXB-2.
引用
收藏
页码:7265 / 7269
页数:5
相关论文
共 54 条
[1]   THE STRUCTURE OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAR RNA REVEALS PRINCIPLES OF RNA RECOGNITION BY TAT PROTEIN [J].
ABOULELA, F ;
KARN, J ;
VARANI, G .
JOURNAL OF MOLECULAR BIOLOGY, 1995, 253 (02) :313-332
[2]   Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNA [J].
Abulwerdi, Fardokht A. ;
Shortridge, Matthew D. ;
Sztuba-Solinska, Joanna ;
Wilson, Robert ;
Le Grice, Stuart F. J. ;
Varani, Gabriele ;
Schneekloth, John S., Jr. .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (24) :11148-11160
[3]   The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism [J].
Bailly, C ;
Colson, P ;
Houssier, C ;
Hamy, F .
NUCLEIC ACIDS RESEARCH, 1996, 24 (08) :1460-1464
[4]   How binding of small molecule and peptide ligands to HIV-1 TAR alters the RNA motional landscape [J].
Bardaro, Michael F., Jr. ;
Shajani, Zahra ;
Patora-Komisarska, Krystyna ;
Robinson, John A. ;
Varani, Gabriele .
NUCLEIC ACIDS RESEARCH, 2009, 37 (05) :1529-1540
[5]  
Barnard Anna, 2015, Angew Chem Weinheim Bergstr Ger, V127, P3003
[6]   Selective and Potent Proteomimetic Inhibitors of Intracellular Protein-Protein Interactions [J].
Barnard, Anna ;
Long, Kerya ;
Martin, Heather L. ;
Miles, Jennifer A. ;
Edwards, Thomas A. ;
Tomlinson, Darren C. ;
Macdonald, Andrew ;
Wilson, Andrew J. .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (10) :2960-2965
[7]   TAT TRANS-ACTIVATES THE HUMAN IMMUNODEFICIENCY VIRUS THROUGH A NASCENT RNA TARGET [J].
BERKHOUT, B ;
SILVERMAN, RH ;
JEANG, KT .
CELL, 1989, 59 (02) :273-282
[8]   The Design of RNA Binders: Targeting the HIV Replication Cycle as a Case Study [J].
Blond, Aurelie ;
Ennifar, Eric ;
Tisne, Carine ;
Micouin, Laurent .
CHEMMEDCHEM, 2014, 9 (09) :1982-1996
[9]   Ligand-induced changes in 2-aminopurine fluorescence as a probe for small molecule binding to HIV-1 TAR RNA [J].
Bradrick, TD ;
Marino, JP .
RNA, 2004, 10 (09) :1459-1468
[10]   Disrupting protein-protein interactions with non-peptidic, small molecule α-helix mimetics [J].
Cummings, Christopher G. ;
Hamilton, Andrew D. .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2010, 14 (03) :341-346